✓ Medically Reviewed Monograph

Febuxostat

Also known as / Synonyms: Febuxostat, Non-Purine Xanthine Oxidase Inhibitor, Antigout

Potent non-purine xanthine oxidase inhibitor tablet that lowers uric acid levels and dissolves painful gout crystals.

🩺
Reviewed by Dr. Lisa M., PharmD
Chief Clinical Editor · Updated November 19, 2026 · Editorial & Fact-Checking Policy
CDSCO & FDA Aligned
📋

Clinical Snapshot & Specifications

Generic Name: Febuxostat
Active Ingredient: Febuxostat
Dosage Form: Tablet
Available Strengths: 40 mg, 80 mg film-coated tablets
Prescription Status: Prescription only (Schedule H / verified)
Approved Routes:
Oral
Popular Verified Brands:
Feburic Zurig Febutaz Uloric (India)
Regulatory Standards: Approved by CDSCO; Schedule H prescription drug in India. US FDA approved with black-box warning for cardiovascular death in patients with established CVD.
🎯

Approved Indications & Medical Uses

  • Chronic management of hyperuricemia in adult patients with gout who have an inadequate response to a maximally titrated dose of allopurinol, who are intolerant to allopurinol, or for whom allopurinol is not clinically advisable.
  • Prevention of recurrent acute gout flares and reduction/dissolution of tophaceous gout deposits.
  • Hyperuricemia associated with tumor lysis syndrome in patients undergoing hematological chemotherapy.
🚫

Contraindications (Do Not Use If…)

  • Concomitant use with azathioprine or 6-mercaptopurine (severe, life-threatening bone marrow toxicity).
  • Known hypersensitivity to febuxostat or formulation components.
  • Treatment of asymptomatic hyperuricemia (not recommended without clinical gout or tophi).
🛡️

Important Clinical Precautions & Warnings

  • Cardiovascular risk: postmarketing cardiovascular safety trials (CARES trial) showed higher rates of cardiovascular death with febuxostat compared to allopurinol; assess cardiovascular risk before prescribing.
  • Gout flare prophylaxis required: an increase in acute gout flares frequently occurs during initiation due to rapid mobilization of urate from tissue deposits; co-prescribe NSAIDs or colchicine prophylaxis for at least the first 6 months.
  • Hepatic effects: postmarketing reports of serious hepatic failure; obtain baseline liver function tests and periodically monitor transaminases.
  • Severe skin reactions: Stevens-Johnson syndrome and DRESS syndrome reported; discontinue immediately if progressive skin rash develops.
  • No dose adjustment in mild-to-moderate renal impairment: unlike allopurinol, febuxostat is eliminated equally via hepatic and renal pathways; safe in renal impairment (eGFR 30-89 mL/min).

Special Populations (Paediatric & Geriatric Care)

Pediatric: Safety and efficacy have not been established in patients under 18 years. Geriatric: Safe and effective; no dose adjustment needed based on age alone.

⚡

Side Effects & Adverse Reactions

ℹ️ Common Side Effects (Usually Mild)

Liver function abnormalities (elevated transaminases), nausea, arthralgia, acute gout flares (initial), diarrhea, and skin rash.

🚨 Serious Side Effects — Seek Urgent Medical Care

Cardiovascular thromboembolic death, acute hepatic failure, Stevens-Johnson syndrome, toxic epidermal necrolysis, and severe hypersensitivity angioedema.

Action: Discontinue medication and seek immediate medical attention or call emergency services if any serious symptom occurs.

🔄

Drug, Food & Substance Interactions

  • Azathioprine and 6-mercaptopurine: STRICTLY CONTRAINDICATED; xanthine oxidase inhibition prevents metabolism of these thiopurines, causing fatal pancytopenia.
  • Theophylline: may increase theophylline plasma concentrations; monitor levels.
  • No clinically significant interactions with colchicine, naproxen, indomethacin, or antacids.
🤰

Pregnancy & Lactation Clinical Safety

Pregnancy Safety:

Use with caution — see notes

There are no adequate and well-controlled studies in pregnant women. Animal reproduction studies did not show teratogenic effects at therapeutic doses. Gout is uncommon in women of childbearing age; use only if clearly needed.

Lactation & Breastfeeding:

Use with caution — see notes

Febuxostat is excreted in animal milk; presence in human breast milk is unknown. Exercise caution when administering to nursing mothers.

📦

Storage, Administration & Overdose Protocol

🌡️ Recommended Storage:

Store tablets at 20°C to 25°C (68°F to 77°F). Protect from light and moisture.

⏱️ Missed Dose Protocol:

Take the missed dose as soon as remembered on that day. If close to the next scheduled dose, skip and resume regular schedule. Do not take a double dose.

🛡️
Clinical & Legal Disclaimer: The clinical monographs and drug information published on 4mg.in are strictly intended for educational, clinical reference, and informational utility. They do not constitute personalized medical advice, diagnosis, or treatment regimens. Always seek the advice of a registered physician or licensed pharmacist regarding specific clinical conditions, prescription dosages, and potential contraindications. Review our comprehensive Editorial & Clinical Fact-Checking Policy.